Multiple Sclerosis Trial, Recruiting NCT06795230 Sponsor: Universidad Rey Juan Carlos Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06795230
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be older than 18 years of age.
  • You must have been diagnosed with Multiple Sclerosis (MS) according to specific medical guidelines, and have had the condition for more than two years.
  • Your level of disability, measured by a standard MS scale called the EDSS, must fall within a specific range — from minimal disability up to being mostly dependent on a wheelchair but still able to transfer and use the toilet independently for part of the day (confirm with trial site for exact score details).
  • You must have been on a stable MS treatment for at least six months before the study begins.
  • The muscle stiffness in your arms must be no more than moderate, meaning your arms can still be moved fairly easily by someone else.
  • The muscle strength in your arms must be at least enough to move against some resistance (confirm with trial site).
  • The problems affecting your movement and strength must be below a certain level on the MS disability scale (confirm with trial site).
  • You must have no significant memory or thinking problems, and must be able to understand instructions, scoring at least 24 out of 30 on a standard cognitive test.
  • Your mental function score on the MS disability scale must be at or below a low level (confirm with trial site).

Who may not be able to join:

  • You have been diagnosed with another neurological disease or a bone, muscle, or joint disorder in addition to MS.
  • You have a heart, lung, or metabolic condition (such as diabetes) or any other health problem that could interfere with the study.
  • You have had an MS relapse or been hospitalised in the three months before the study starts, or during the treatment period.
  • You have received steroid treatment (by injection or by mouth) in the six months before the study begins or during the study period.
  • You have received botulinum toxin (Botox) injections in the six months before the study starts.
  • The stiffness in your muscles is above a moderate level on the standard scale used in this study.
  • You have cognitive (thinking) or language difficulties that would prevent you from communicating or understanding instructions clearly.
  • You have a history of serious circulatory problems, such as deep vein thrombosis (blood clots in the legs), pulmonary embolism (blood clots in the lungs), vascular disease, a blood clotting disorder, or any other circulation or coagulation problem.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roberto Cano de la Cuerda, PT, PhD, Universidad Rey Juan Carlos

Phone: +34914888674

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad Rey Juan Carlos
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Isometric prehensile hand strength (Kg)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov